Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Growth in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 61,662 shares, an increase of 274.3% from the June 30th total of 16,476 shares. Approximately 12.1% of the shares of the stock are short sold. Based on an average trading volume of 256,414 shares, the short-interest ratio is presently 0.2 days.

Autonomix Medical Stock Down 16.6%

NASDAQ AMIX traded down $0.58 on Friday, reaching $2.92. The company had a trading volume of 7,992,176 shares, compared to its average volume of 230,123. The stock has a market capitalization of $1.58 million, a PE ratio of -0.04 and a beta of -1.32. Autonomix Medical has a 12 month low of $2.90 and a 12 month high of $32.55. The firm’s 50 day moving average price is $6.95 and its 200 day moving average price is $8.02.

Analysts Set New Price Targets

Several analysts recently issued reports on AMIX shares. Zacks Research raised Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings downgraded Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a research note on Friday, July 10th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $42.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.